Accepted for/Published in: JMIR Formative Research
Date Submitted: Jun 20, 2022
Date Accepted: Feb 14, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Patient Feedback
ABSTRACT
Background:
Opioid use disorders (OUD) impact the health and well-being of millions of Americans. Buprenorphine or buprenorphine/naloxone (BUP/NAL) can reduce opioid overdose deaths, decrease misuse, and improve quality of life. Unfortunately, poor medication adherence is a primary barrier to long-term efficacy of BUP/NAL.
Objective:
The intent of this investigation was to examine qualitative and quantitative patient feedback on a Bluetooth-enabled pill bottle cap and associated mobile application for patients prescribed BUP/NAL for an OUD.
Methods:
A convenience sample at an OUD outpatient clinic were asked about medication adherence, opioid cravings, experience with technology, and their existent support system through a brief, electronic survey. Patients also provided detailed feedback on features being considered for inclusion in a new technology designed to increase medication adherence, such as inclusion of a personal motivational factor, craving and stress tracking, incentives, and virtual coaching.
Results:
Twenty people (n=20) with an OUD who were prescribed BUP/NAL participated. Participants mean age was 34 years, 65% were female, and 80% Caucasian. Participants had the opportunity to select the most useful, second most useful, and least useful features presented; the large majority indicated that motivational reminders would be most useful (42.1%), followed by craving and stress tracking (26.3%) and online support forums (21.1%).
Conclusions:
Incorporating these suggestions for the described pill-bottle technology may encourage the use of the platform, as well as allow technology developers and BUP/NAL providers to modify this tool for different patient populations. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.